MedTrace Logo

Ambulatory Laparoscopic Sleeve Gastrectomy

NCT05106660 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1554

Last updated 2021-11-04

No results posted yet for this study

Summary

In the era of laparoscopic surgery, day case procedures are increasingly practiced around the world, however, day case bariatric surgery remains a controversial issue due to lack of sufficient evidence evaluating its safety. Laparoscopic sleeve gastrectomy (LSG) is currently the most popular bariatric surgery performed worldwide, and the standard is 1-2 days postop stay. However, the American College of Surgeons and the American Society for Metabolic and Bariatric Surgery released guidelines in 2016 that allowed LSG in ambulatory surgery centers for low acuity patients. In the present trial, investigators will compare the safety and feasibility of same day discharge vs next day discharge in a large group of patients undergoing laparoscopic sleeve gastrectomy.

Conditions

  • Obesity, Morbid

Interventions

PROCEDURE

Ambulatory Laparoscopic Sleeve Gastrectomy

Same-day discharge

PROCEDURE

Conventional Laparoscopic Sleeve Gastrectomy

Next-day discharge

Sponsors & Collaborators

  • New You Medical Center

    collaborator UNKNOWN

  • King Saud University

    lead OTHER

Principal Investigators

  • Aayed Alqahtani, MD FRCSC · New You Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2020-12-01
Completion
2020-12-01

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05106660 on ClinicalTrials.gov